An analysis of data from more than 30,000 breast cancer patients in Finland showed that statin use before and after diagnosis was linked to reduced mortality risk of up to 66%. "The association held for both localized and metastatic tumors. There really appears to be something going on here, and it's certainly a reason for further study," a researcher said. The findings were presented at the annual meeting of the American Association for Cancer Research.
Statins may cut death risk in breast cancer patients
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||